The present invention relates to an abrasion device and method. More particularly, the present invention relates to an abrasion device and method for painlessly and bloodlessly sampling skin for analysis.
Demonstrating efficacy of technology on human subjects is an essential part of successful achievement of commercialization of such technology. Human trials aimed at identifying benefits of a technology, such as a skin benefit technology, often require three to six months duration to visualize measurable effect. For example, retinoids are a particularly potent anti-aging technology in skin care, however, even retinoids require this lengthy period to elicit a visual change. Shorter term, e.g. 1 week, human studies may be developed. These shorter term stuedes are especially useful for screening or ranking a number of potential actives. Short term human studies rely on the collection of skin tissue samples which are typically undertaken by physicians taking relatively invasive biopsies of the skin, either full thickness (dermis and epidermis) or shave biopsies. These invasive skin sampling methods generally provide more tissue than is actually required for many assays for biomarkers that may indicate long term clinical efficacy after short term treatment.
Currently used sampling techniques include the following: full thickness punch biopsies, “nick” (small shave) biopsies and blister biopsies. Full thickness punch biopsies entail use of a razor-edged circular punch and a scalpel to remove a piece of tissue that can extend further than the dermis. “Nick”, or small shave, biopsies involve the use of a scalpel to remove a pinched up portion of the skin surface. The full thickness punch biopsy and the shave biopsy techniques present the subject with considerable discomfort, require anesthesia (requiring administration by a physician), and pose potential harm. Methods of this type, involving gross removal of skin tissue in a procedure that is essentially surgical include: U.S. Pat. No. 5,325,857, U.S. Pat. No. 5,394,886, U.S. Pat. No. 5,380,337 and U.S. Pat. No. 5,570,700. Blister biopsies require the use of a vacuum applied to the skin surface to produce a blister, which is removed by scalpel. Suction blister epidermal sampling provides the desired epidermal samples, however, this method requires a blistering period of about two hours, during which time changes can occur to the biochemistry of the epidermal skin cells, such as the degradation of RNA.
Dermabrasion tools and techniques used in treating pitted and disfigured skin involve what are essentially power tools and involve no harvesting and processing of sampled tissue material. U.S. Pat. No. 6,423,078 relates to surgical abrasion using diamond grit and U.S. Pat. No. 5,800,446 relates to an abrasive tip, however, both of these devices remove considerably more tissue than they are able to harvest.
There is a need for a sampling device and technique that does not require the presence of a physician, is minimally invasive, does not remove excess tissue, can be done with minimal discomfort and that provides a sample large enough for modern biochemical analysis.
To attenuate the shortcomings of prior devices and techniques, a novel abrasion device assembly and epidermal sampling technique have been developed.
In a first aspect, the present invention provides an abrasion device for sampling small amounts of epidermal cells from a skin surface of an individual. The assembly includes an actuator device comprising a central shaft conjoined with a handle device having a handle extending from it. The central shaft has a central opening therein. The assembly is further provided with a probe disposed centrally and releasably within the central opening of the actuator device. The probe comprises a cylindrical rod having a distal end and terminating in an abrasive surface at a cross-sectional proximal end thereof. The abrasive surface is appropriately textured and has a small cross-sectional diameter for abrasion and harvesting of epidermal cells. A cylindrical positioning sleeve is provided, comprising a cylindrical rod having a central opening therein of a larger diameter than the central shaft. The cylindrical rod has a proximal end and a distal end, a threaded surface extending from a selected position on said cylindrical rod and terminating at distal end. The positioning sleeve further includes a first locking ring adjustably positioned along the threaded surface and a second locking ring adjustably positioned from the distal end to adjacent the first locking ring. The positioning sleeve is releasably and adjustably positioned over the actuator device so that a desired length of the probe extends therefrom.
In a second aspect, the present invention provides a method for sampling small amounts of epidermal cells from a skin surface of an individual using the abrasion device in accordance with the first aspect. Upon being pressed against the skin surface with the abrasive surface, the probe abrades a small sample of epidermal tissue.
In another aspect, the present invention is a kit including the abrasion device in accordance with the first aspect. The kit is suitable for consumer use and does not require a physician's assistance.
In a further aspect, the present invention provides a method for assembling the abrasion device in accordance with the first aspect. Assembly includes the steps of: (a) securing the collet to the driver rod, (b) inserting the probe into the collet, (c) inserting the secured driver rod in the central opening of the central shaft of the actuator device, (d) tightening the knurled disc over the actuator device, thereby securing the driver rod therein and forcing the collet to grip the probe, and (e) sliding the positioning sleeve over the central shaft; thereby allowing a desired length of probe to protrude and extend beyond the proximal end of the positioning sleeve.
For a more complete understanding of the above and other features and advantages of the invention, reference should be made to the following description of the preferred embodiment.
The invention will be better understood by way of the following detailed description of a preferred embodiment, with reference to the appended drawings in which:
As used herein, the term “comprising” means including, made up of, composed of, consisting and/or consisting essentially of. Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts or ratios of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word “about”.
The term “harvesting” as used herein refers to the picking up of debris of abraded epidermal cells.
The term “skin” as used herein includes the skin on or in the face, mouth (epithelial cells), neck, chest, back, arms, hands, legs, and scalp.
The device and method of the present invention involve the removal of the upper skin layer with a manual, mechanically driven abrasive probe. Using the inventive device and method, the epidermis, including the basal layer of the epidermis, is removed, thereby effectively sampling the whole epidermis. Various quantities of epidermis may be obtained by varying the diameter of the probe. The small quantities of epidermis obtained using the inventive device and method have been found to have great utility in a variety of bio-analytical applications, such as determinations of RNA, protein, genomic DNA, minerals and other metabolites.
With reference to
With reference to
With reference to
With reference to
With reference to
Peaks 58 and troughs 60 may be of any three-dimensional shape, thereby having any cross-sectional shape. Preferably, for better abrasion, the cross-sectional shape of peaks 58 (or troughs 60 in the absence of peaks 58) includes an angle relative to the plane of flat surface area 56, such as that of a triangle, rectangle, hemisphere, trapezoid, or another geometry including an angle. More preferably, the cross-sectional geometrical shape includes a sharp angle that will form a sharp edge in the overall three-dimensional shape of peaks 58 or troughs 60.
Most preferably, the cross-sectional geometry of troughs 60 is a hemisphere for maximum capacity.
In one aspect of the invention, abrasive surface 38 may be comprised of only troughs 60. In another aspect, abrasive surface 38 may be comprised of only peaks 58.
The number and size of peaks 58 and troughs 60 is determined by the criteria that the Harvesting Volume be greater than or equal to the Abrasion Volume. Harvesting Volume as referred to herein is intended to mean the volume capacity of the sum of the volumes of troughs 60 plus the interstitial volume between peaks 58 (if any), while Abrasion Volume as referred to herein is intended to mean the volume of skin sample collected. This criteria ensures that substantially all the tissue abraded shall be harvested.
With reference to
In use, after sterilizing probe 14 and assembling abrasion device 10, positioning sleeve 16 is held such that second locking ring 54 is at distal end 24 of central shaft 20 of actuator device 12, adjacent handle 28 thereof. Handle 28 is rotated manually, causing central shaft 20 to rotate within positioning sleeve 16, thereby causing rotation of probe 14, wherein upon being pressed lightly against the skin surface with abrasive surface 38, probe 14 is capable of abrading a small sample of epidermal tissue by the rotating action against the skin. Second locking ring 54 may be adjusted along threaded surface 48, causing it to move closer or further from first locking ring 52, thereby adjusting the length of positioning sleeve 16. Adjusting the overall length of positioning sleeve 16 in turn adjusts the desired length 18 of protrusion of probe 14, thereby allowing for control of pressure applied to the skin and preventing excessive penetration of the skin. Flat surface area 56 of abrasive surface 38 of probe 14 also provides control of the depth of abrasion, as the probe will tend not to penetrate beyond the contact of skin with flat surface area 56. Rotation effectively removes epidermal tissue, which adheres to abrasive surface 38. Small amounts of epidermal tissue are removed, preferably about 0.00001 cu cm to about 0.001 cu cm, more preferably about 0.0003 cu cm (about 300 micro g). After the sample is taken, probe 14 is released from collet 33, and the epidermal sample collected on or in abrasive surface 38 may be submitted for analysis. Suitable analyses include determination of biochemical markers, RNA, protein, genomic DNA, minerals and other metabolites.
Abrasion device 10 allows quick, substantially bloodless epidermal sample excission (unlike biopsies), and leaves minimal or no residual scar (unlike surgical biopsies). Compared to the suction blistering technique, which takes about two hours and punch biopsy, which takes about two minutes, abrasion may be performed in about 0.001 to about 60 seconds, preferably about 10 to about 30 seconds. The speed of sampling offers the advantage of obtaining real time samples and limits sample degradation.
This example demonstrates the use of abrasion device 10 to provide efficient epidermal tissue collection with a substantial absence of scar, as compared to that by punch biopsy. Scar scores were obtained from grading 3 subjects in a clinical study in which both punch biopsies and epidermal abrasions were taken.
Abrasion device 10 was used in accordance with the method described hereinabove.
The punch biopsy procedure used in the study is as follows: A site on the forearm is anesthesized (via injection) with 1% Lidocaine with epinephrine and allowed to get numb. A 3 mm Accupunch (brand name) sterile, disposable biopsy punch is used to take the biopsy. The site on the skin is closed with one suture, then Bacitracin and a band-aid are applied. The suture is removed about 10 days later.
Test sites on three clinical study subjects who had punch biopsy and epidermal abrasion procedures conducted in a recent human clinical study were examined by clinicians to determine the level of scarring induced by both procedures. An index of 0–4 was used (see the Tables below).
All of the 9 punch biopsy sites had visible scars from the punch biopsy procedure. None of the epidermal abrasion sites (144 sites in total—6 abrasions×4 time points×2 sites=48 sites per subject×3 subjects=144 sites) exhibited any scarring from the epidermal abrasion procedure.
The inventive device and method advantageously provide efficiency, minimal discomfort, avoidance of excess tissue removal and scarring, and the capability to efficiently harvest and collect epidermal samples for analysis. The small amount of epidermis sampled results in minimal discomfort to the subject and a substantial absence of scar. The device therefore lends itself to multiple sampling from one individual. Therefore, the device and method are useful in investigations of individual variation in skin biology and product efficacy, such as for example providing crucial tissue sampling to enable genomic analysis of skin to be assessed before and after product application. The device and method may also be useful in skin diagnostic activities.
This technique could be widely employed in clinical testing as it is minimally invasive and much more acceptable to subjects than current sampling methods. It also may be capable of adaptation for home-use skin sampling/analysis kits, which may include abrasion device assembly 10 together with instructions for use and analysis and an analytical device.
While the present invention has been described herein with some specificity, and with reference to certain preferred embodiments thereof, those of ordinary skill in the art will recognize numerous variations, modifications and substitutions of that which has been described which can be made, and which are within the scope and spirit of the invention. It is intended that all of these modifications and variations be within the scope of the present invention as described and claimed herein, and that the inventions be limited only by the scope of the claims which follow, and that such claims be interpreted as broadly as is reasonable. Throughout this application, various publications have been cited. The entireties of each of these publications are hereby incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2712823 | Kurtin | Jul 1955 | A |
2867214 | Wilson | Jan 1959 | A |
3468079 | Kaufman | Sep 1969 | A |
4274419 | Tam et al. | Jun 1981 | A |
4538612 | Patrick, Jr. | Sep 1985 | A |
5325857 | Nabai et al. | Jul 1994 | A |
5380337 | Romaine | Jan 1995 | A |
5394886 | Nabai et al. | Mar 1995 | A |
5570700 | Vogeler | Nov 1996 | A |
5707383 | Bays et al. | Jan 1998 | A |
5800446 | Banuchi | Sep 1998 | A |
5879326 | Godshall et al. | Mar 1999 | A |
5888034 | Greenberg | Mar 1999 | A |
6136008 | Becker et al. | Oct 2000 | A |
6241739 | Waldron | Jun 2001 | B1 |
6258044 | Lonky et al. | Jul 2001 | B1 |
6283978 | Cheski et al. | Sep 2001 | B1 |
6299620 | Shadduck et al. | Oct 2001 | B1 |
6387103 | Shadduck | May 2002 | B1 |
6423078 | Bays et al. | Jul 2002 | B1 |
20010018061 | Rhoades | Aug 2001 | A1 |
20020045907 | Sherman et al. | Apr 2002 | A1 |
20020087167 | Winitsky | Jul 2002 | A1 |
20020087168 | Winitsky | Jul 2002 | A1 |
20020107527 | Burres | Aug 2002 | A1 |
20020123675 | Trautman et al. | Sep 2002 | A1 |
20020143345 | Koefer et al. | Oct 2002 | A1 |
Number | Date | Country |
---|---|---|
1 086 719 | Mar 2001 | EP |
1 219 254 | Mar 2002 | EP |
100 446 | Oct 1916 | GB |
2 278 282 | Nov 1994 | GB |
0232331 | Apr 2002 | WO |
Number | Date | Country | |
---|---|---|---|
20040162565 A1 | Aug 2004 | US |